GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Long-Term Debt

China National Accord Medicines (SZSE:000028) Long-Term Debt

: ¥0 Mil (As of Dec. 2023)
View and export this data going back to 1993. Start your Free Trial

China National Accord Medicines's Long-Term Debt for the quarter that ended in Dec. 2023 was ¥0 Mil.

China National Accord Medicines's quarterly Long-Term Debt declined from Jun. 2023 (¥10 Mil) to Sep. 2023 (¥0 Mil) but then stayed the same from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥0 Mil).

China National Accord Medicines's annual Long-Term Debt declined from Dec. 2021 (¥72 Mil) to Dec. 2022 (¥18 Mil) and declined from Dec. 2022 (¥18 Mil) to Dec. 2023 (¥0 Mil).


China National Accord Medicines Long-Term Debt Historical Data

The historical data trend for China National Accord Medicines's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 31.64 71.64 17.50 -

China National Accord Medicines Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Long-Term Debt Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.50 17.00 9.50 - -

China National Accord Medicines  (SZSE:000028) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


China National Accord Medicines Long-Term Debt Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines